臨床婦人科産科78巻6号

2024年06月発行

今月の臨床 子宮頸がん撲滅へ向けた戦略―ワクチンと検診の新たなトレンドは？

総論

子宮頸がんの発がん機序とその制御

著者： 川名敬¹

所属機関： ¹日本大学医学部産婦人科学系産婦人科学分野

ページ範囲：P.480 - P.488

文献概要

●HPV感染をワクチンによって免疫学的に予防することが有効である．

●HPV感染からがん化へのメカニズムは解明されてきたが，HPVに対する宿主の免疫学的な個人差が発症や病変進行の差になる．

●HPV（予防）ワクチンの世界的普及を目指しつつ，第2の予防としてHPV治療ワクチンによるHPV感染制御も期待される．

参考文献

1）zur Hausen H : Papillomavirus and cancer : from basic studies to clinical application. Nat Rev Cancer 2 : 342-350, 2002

2）You J：Papillomavirus interaction with cellular chromatin. Biochim Biophys Acta 1799 : 192-199, 2010

3）Bosch FX, et al : Chapter 1 : Human papillomavirus and cervical cancer―burden and assessment of causality. J Natl Cancer Inst Monogr 31 : 3-13, 2003

4）Ho GYF, et al : Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338 : 423-428, 1998

5）Canfell K, et al : Mortality impact of achieving WHO cervical cancer elimination targets : a comparative modelling analysis in 78 low-income and lower-middle-income countries, Lancet 395 : 591-603, 2020

6）Prudden HJ, et al : Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus（HPV）vaccines : World Health Organization consultations, October 2021-March 2022. Vaccine 40 : 5843-5855, 2022

7）Bruni L, et al : Global estimates of human papillomavirus vaccination coverage by region and income level : a pooled analysis. Lancet Glob Health 4 : e453-e463, 2016

8）Franco EL, et al : Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 180 : 1415-1423, 1999

9）Holowaty P, et al : Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91 : 252-258, 1999

10）Matsumoto K, et al : Predicting the progression of cervical precursor lesions by human papillomavirus genotyping : a prospective cohort study. Int J Cancer 128 : 2898-2910, 2011

11）Mirkovic J, et al : Carcinogenic HPV infection in the cervical squamo-columnar junction. J Pathol 236 : 265-271, 2015

12）Hu Z, et al : Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism, Nat Genet 47 : 158-163, 2015

13）Kukimoto I, et al : Hypermutation in the E2 gene of human papillomavirus type 16 in cervical intraepithelial neoplasia. J Med Virol 87 : 1754-1760, 2015

14）Gravitt PE：The known unknowns of HPV natural history. J Clin Invest 121 : 4593-4599, 2011

15）Insinga RP, et al ; the FUTURE Investigators：Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev 19 : 1585-1594, 2010

16）Kawana K, et al : Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3. JNCI Cancer Spectr 7 : pkad101, 2023